Nature Communications (Jun 2022)

Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios

  • Kun-yin Qiu,
  • Xiong-yu Liao,
  • Yong Liu,
  • Ke Huang,
  • Yang Li,
  • Jian-pei Fang,
  • Dun-hua Zhou

DOI
https://doi.org/10.1038/s41467-022-31489-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 12

Abstract

Read online

Activating FLT3 mutations are the most common mutations in AML. Here, the authors explore the relationship between the FLT3/ITD allelic ratio and prognosis in pediatric AML patients and identify an optimal threshold to stratify patients.